EQS-News: Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose
EQS-News: Marinomed Biotech AG / Key word(s): Preliminary Results
Marinomed Biotech AG announces preliminary revenue for 2022 with
double-digit growth for Carragelose
16.02.2023 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Marinomed Biotech AG announces preliminary revenue for 2022 with
double-digit growth for Carragelose
• Major strategic developments in 2022 to boost future growth
• Preliminary!-->…